Table:
begin	end	state
1	20	cytoplasmic
21	45	transmembrane
46	56	non-cytoplasmic
57	80	transmembrane
81	91	cytoplasmic
92	111	transmembrane
112	115	non-cytoplasmic
116	116	transmembrane
117	117	non-cytoplasmic
118	140	transmembrane
141	163	cytoplasmic
164	184	transmembrane
185	200	non-cytoplasmic
201	220	transmembrane
221	252	cytoplasmic
253	275	transmembrane
276	298	non-cytoplasmic
299	320	transmembrane
321	328	cytoplasmic
329	348	transmembrane
349	354	non-cytoplasmic
355	377	transmembrane
378	391	cytoplasmic
392	414	transmembrane
415	419	non-cytoplasmic
420	441	transmembrane
442	451	cytoplasmic

Input:
>WP_090273468.1 NCBI__GCF_900105005.1:WP_090273468.1
MPENIVSSQEAPANSRSRVMLASLVGTTIEFYDFYVYATAAVLVFPHLFFPPGNETIALL
ASFAIFGAAMIARPLGAVFFGHLGDKVGRKKTLIYALFTMGVATFLIGLLPTYHAIGWWA
PLLLVIMRLAQGFAIGGEWSGAALVATENAPAGKRALFGTFPQLGAPLGFIIANGLFLIV
AAALPSDDPSRPSEAFLDWGWRIPFLFSAVMVIIGLWIRLNLVESKTFSKTVSAGKVVKL
PLGEVMRKNWRELILGTFYMLATYVLFYLMTTFSLSYGRAPIEPAAGQLSGLGYSYNNFV
LMLIVGVVFFGIFTLLSGLVADRLGRRKTLILVTLGIIGFSLLWVPLLNMGFVGVMAWLI
LGFSLMGMTFGPMGALLPELFPTNVRYTGSGISYNVSSILGAAVAPFIAVWLWSVGDGSP
FLVGVYLASMAFITLIALVVGKETKNVDINH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server